ESC 365 - Doctor Patrick Moriarty

Speaker illustration

Doctor Patrick Moriarty

University of Kansas Medical Center, Kansas City (United States of America)

The change in HDL proteomics following lipid-apheresis therapy

Event: ESC Congress 2018

Topic: Lipids, Other

Session: Preventive cardiology / Lipids

Efficacy and Safety of Evolocumab Compared With Continued Lipoprotein Apheresis: Results of a Randomised, Controlled, Open-Label Study

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Late-Breaking Science Posters

ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

Event: ESC Congress 2016

Topic: Lipids

Session: Hot Line prevention and lipids

Pitavastatin lowers plasma levels of CoQ10 less than equipotent doses of rosuvastatin or atorvastatin

Event: ESC Congress 2016

Topic: Lipids

Session: Cardiovascular cell biology

ESC 365 is supported by